CVRx (CVRX) FCF Margin (2020 - 2026)
CVRx's quarterly FCF Margin came in at 83.19% in Q1 2026, up 2113.0% year-on-year from 3.76% in Q1 2025, and down 35.66% quarter-over-quarter from 61.32% in Q4 2025.
CVRx has reported FCF Margin for 7 years, with the latest figure at 83.19% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin rose 2113.0% year-over-year to 83.19%; the trailing twelve-month figure through Mar 2026 stood at 67.98% (up 1066.0% YoY), and the FY2025 full-year result was 71.93%, up 704.0% from the prior year.
- FCF Margin for Q1 2026 stood at 83.19%, down from 61.32% in the prior quarter.
- The five-year high for FCF Margin was 52.54% in Q4 2024, with the low at 268.33% in Q1 2022.
- Average FCF Margin over 5 years is 113.22%, with a median of 86.26% recorded in 2024.
- Year-over-year, FCF Margin slumped 8864 bps in 2022 and jumped 13687 bps in 2023.
- Tracing CVRX's FCF Margin over 5 years: stood at 152.17% in 2022, then surged by 53 bps to 70.84% in 2023, then increased by 26 bps to 52.54% in 2024, then decreased by 17 bps to 61.32% in 2025, then tumbled by 36 bps to 83.19% in 2026.
- The last three FCF Margin figures came in at 83.19% (Q1 2026), 61.32% (Q4 2025), and 68.1% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.44% |
| 10 | CVRx | 144.43 Mn | 72.13 Mn | 12.88 Mn | -83.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -83.19% |
| Dec 31, 2025 | -61.32% |
| Sep 30, 2025 | -68.10% |
| Jun 30, 2025 | -59.16% |
| Mar 31, 2025 | -104.32% |
| Dec 31, 2024 | -52.54% |
| Sep 30, 2024 | -78.12% |
| Jun 30, 2024 | -86.26% |
| Mar 31, 2024 | -109.68% |
| Dec 31, 2023 | -70.84% |
| Sep 30, 2023 | -77.67% |
| Jun 30, 2023 | -136.33% |
| Mar 31, 2023 | -131.46% |
| Dec 31, 2022 | -152.17% |
| Sep 30, 2022 | -183.64% |
| Jun 30, 2022 | -201.65% |
| Mar 31, 2022 | -268.33% |
| Dec 31, 2021 | -206.48% |
| Sep 30, 2021 | -276.29% |
| Jun 30, 2021 | -219.12% |
| Mar 31, 2021 | -179.69% |
| Dec 31, 2020 | -200.43% |
| Sep 30, 2020 | -529.09% |